ELMOD3

ELMOD3 is an ELMO-domain-containing GTPase-activating protein that regulates actin cytoskeletal integrity in sensory hair cells and epithelial cells, vesicle trafficking from the Golgi to cilia, and signaling through ARF/ARL-family GTPases. Its ELMO domain catalyzes GTP hydrolysis on ARL2 in vitro, and this activity is essential for co-localization with F-actin in epithelial microvilli and hair-cell stereocilia; disease-associated mutations (e.g., p.Leu265Ser, p.His171Arg) abolish GAP activity, disrupt actin association, and accelerate protein degradation (PMID:24039609, PMID:29713870). Knockout of Elmod3 in mice causes progressive sensorineural hearing loss with stereocilia shortening, fusion, and loss of F-actin, establishing ELMOD3 as essential for cochlear hair-cell maintenance (PMID:31628468). ELMOD3 also promotes primary ciliogenesis by facilitating Golgi-to-cilia protein trafficking upstream of ARL3 and ARL16, and in gastric cancer cells it interacts with β-catenin via its ELMO domain to activate Wnt target gene expression and RAF/MEK/ERK signaling (PMID:34818063, PMID:39621020).

1. 2013 High

   Establishing the enzymatic identity of ELMOD3 as an ARL2 GAP and linking its ELMO domain to actin association resolved the question of what molecular activity the protein provides and where it acts in cells.

   Evidence In vitro GAP assay with recombinant GST-ELMOD3, mutagenesis of p.Leu265Ser, and fluorescence co-localization with actin in MDCK and LLC-PK1-CL4 cells; immunofluorescence in rodent cochlea

   PMID:24039609

   Open questions at the time

   • No structure of the ELMO domain bound to ARL2 is available
   • Substrate selectivity across the broader ARF/ARL family was not tested
   • Mechanism by which GAP activity promotes actin co-localization is unclear
2. 2018 Medium

   Demonstrating that the p.His171Arg mutation destabilizes ELMOD3 protein and mislocalizes it provided a second independent disease-associated mechanism (protein instability) beyond catalytic loss.

   Evidence Immunofluorescence and Western blot protein decay assays comparing wild-type and p.His171Arg ELMOD3 in cell lines

   PMID:29713870

   Open questions at the time

   • Degradation pathway (proteasomal vs. lysosomal) not identified
   • Whether reduced protein levels alone explain pathogenicity or whether mislocalization contributes independently is unresolved
3. 2019 High

   Elmod3 knockout mice established that ELMOD3 is required in vivo for maintaining stereocilia actin architecture and hearing, converting the gene from a candidate to a validated deafness gene.

   Evidence CRISPR/Cas9 Elmod3 knockout mouse; auditory brainstem response; confocal imaging of stereocilia morphology and F-actin

   PMID:31628468

   Open questions at the time

   • Whether ELMOD3 acts cell-autonomously in hair cells versus supporting cells was not tested
   • Direct ARL2-dependent step in stereocilia maintenance not demonstrated in vivo
   • Rescue with wild-type ELMOD3 was not shown
4. 2021 High

   Deletion of Elmod3 in MEFs revealed a second major cellular function—regulation of Golgi-to-cilia vesicle trafficking—and epistasis with constitutively active ARL3/ARL16 placed ELMOD3 upstream in a GTPase signaling cascade controlling ciliogenesis.

   Evidence Elmod3-deleted MEFs; immunofluorescence of cilia and Golgi markers; rescue by activating ARL3 and ARL16 mutants

   PMID:34818063

   Open questions at the time

   • Direct GAP activity of ELMOD3 toward ARL3 or ARL16 was not biochemically tested
   • Whether the cilia phenotype contributes to the hearing loss in Elmod3 KO mice is unknown
   • Cargo identity in the Golgi-to-cilia trafficking pathway is not defined
5. 2023 Medium

   ELMOD3 was shown to interact with Rab1A and Flotillin2 and to regulate apical membrane vesicle trafficking in Ciona notochord, extending its vesicle trafficking role to a non-mammalian system and revealing new physical partners.

   Evidence Co-IP/pulldown assays and loss-of-function/rescue experiments in Ciona notochord

   PMID:36918025

   Open questions at the time

   • Whether the ELMOD3–Rab1A interaction is conserved in mammals is untested
   • Whether ELMOD3 acts as a GAP for Rab1A or functions through a non-catalytic mechanism is unknown
   • Single invertebrate model system; awaits independent replication
6. 2024 Medium

   Discovery that ELMOD3's ELMO domain directly binds β-catenin to potentiate Wnt and RAF/MEK/ERK signaling in gastric cancer cells opened an unexpected oncogenic signaling role distinct from its GTPase and actin functions.

   Evidence Co-IP of ELMO domain with β-catenin; ELMOD3 knockout gastric cancer cells; xenograft model; Western blot pathway analysis

   PMID:39621020

   Open questions at the time

   • Whether β-catenin interaction depends on ELMOD3 GAP activity is untested
   • Single cancer type examined; generalizability unknown
   • Mechanism linking ELMOD3 to RAF/MEK/ERK (direct vs. β-catenin-mediated) is unresolved

• The structural basis of ELMO-domain substrate recognition, the full spectrum of GTPase targets, and whether the ciliary, actin, and Wnt/ERK functions are mechanistically coupled or independent remain unresolved.
• No crystal or cryo-EM structure of ELMOD3 alone or in complex with any GTPase
• Systematic GAP activity profiling across ARF/ARL/Rab family members has not been performed
• Whether the ciliogenesis defect and the stereocilia/actin defect share a common trafficking mechanism is unknown